1/52
Vocabulary-style flashcards covering the mammalian host immune system, including innate and adaptive responses, chemical mediators, the complement system, and lymphoid tissues.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Immunity
The ability of the host to resist infection or disease.
Innate (Nonspecific) Immunity
The first line of defence against infection present from birth that responds broadly to microbes and does not generate immunological memory.
Adaptive (Specific) Immunity
Immunity that targets specific pathogens or antigens following exposure or vaccination, characterized by a slower initial response and the generation of immunological memory.
Lysozyme
An enzyme produced by mucous membranes that breaks down bacterial cell walls by targeting peptidoglycan.
Lactoferrin
A substance produced by mucous membranes that binds iron, limiting bacterial growth.
Mucociliary escalator
The process where cilia move mucus and trapped microbes away from the lungs to be removed by coughing, sneezing, or swallowing.
Alveolar macrophages
Phagocytic immune cells located in the alveoli that engulf and destroy microbes reaching the lower respiratory tract.
Gut-associated lymphoid tissue (GALT)
Lymphoid tissue in the gastrointestinal tract that monitors pathogens and activates immune responses.
Paneth cells
Cells located in the intestinal epithelium that produce antimicrobial substances including lysozyme and defensins (also known as cryptdins/cryptins).
Cathelicidins
Linear α-helical antimicrobial peptides lacking cysteine residues, produced by neutrophils, respiratory and urogenital epithelial cells, and alveolar macrophages.
Defensins
Antimicrobial peptides produced as precursor proteins; α-defensins are produced by neutrophils and Paneth cells, while β-defensins are produced mainly by epithelial cells.
Histatins
Antimicrobial peptides present in saliva that possess antifungal activity.
Bacteriocins
Antimicrobial peptides produced by normal microbiota that inhibit closely related bacterial species, such as colicins by E. coli and lantibiotics by Gram-positive bacteria.
Opsonisation
A process where microbes are coated by opsonins (e.g., C3b or antibodies) to enhance recognition and ingestion by phagocytes.
Membrane Attack Complex (MAC)
A pore-forming structure composed of C5b, C6, C7, C8, and 10–19 polymerised molecules of C9 that causes cell lysis by disrupting membrane integrity.
Classical pathway
A complement system activation pathway usually triggered by antigen–antibody complexes, linking the complement system to adaptive immunity.
Lectin pathway
A complement activation pathway initiated by mannose-binding lectin (MBL) binding to specific carbohydrates on microbial surfaces.
Alternative pathway
A rapid, nonspecific complement pathway triggered by direct interaction between complement proteins and repetitive structures on microbial surfaces, particularly effective against Gram-negative bacteria.
Cytokines
Soluble proteins or glycoproteins released by immune cells that act as signalling molecules to coordinate communication between different parts of the immune system.
Monokines
Cytokines released by mononuclear phagocytes such as macrophages.
Interleukins
Cytokines released by one leukocyte that act on other leukocytes.
Colony-stimulating factors (CSFs)
Cytokines that stimulate the growth and differentiation of immature leukocytes in the bone marrow.
Neutrophils (PMNs)
The most abundant granulocyte in the blood (∼60% of WBCs) which migrate to sites of infection and kill ingested microbes using lytic enzymes and reactive oxygen metabolites.
Eosinophils
Granulocytes (∼3% of WBCs) that defend against protozoan and helminth parasites and contribute to allergic reactions.
Basophils
Nonphagocytic granulocytes (∼1% of WBCs) that release vasoactive mediators like histamine and serotonin, playing roles in allergies and inflammation.
Mast Cells
Bone marrow-derived cells in connective tissues containing granules with histamine and heparin that respond to infection, injury, and allergens.
Macrophages
Tissue-resident phagocytic cells derived from monocytes that initiate inflammation and possess pattern recognition receptors (PRRs) to recognize pathogens.
Dendritic Cells
Sentinel immune cells with neuron-like appendages that capture and process antigens to present them to T lymphocytes, linking innate and adaptive immunity.
Epitopes
The specific antigenic determinant sites on a molecule recognised by an antibody or T-cell receptor.
Antibody Affinity
The strength of binding between one antibody-binding site and one epitope.
Avidity
The overall strength of binding between an antibody and antigen across multiple binding sites.
Antigen-presenting cells (APCs)
Cells like macrophages and dendritic cells that process and display antigen fragments on their surface bound to MHC molecules to activate T lymphocytes.
Natural Killer (NK) Cells
Large granular, non-phagocytic lymphocytes that destroy virus-infected or malignant cells by releasing perforin and granzymes.
Major Histocompatibility Complex (MHC)
A collection of genes (HLA complex on chromosome 6 in humans) involved in self vs non-self recognition and antigen presentation.
MHC I
Molecules found on almost all nucleated cells that present intracellular antigens to CD8+ cytotoxic T cells.
MHC II
Molecules found only on antigen-presenting cells (APCs) that present foreign antigens to activate CD4+ helper T cells.
Primary Lymphoid Organs
Sites including the bone marrow and thymus where lymphocytes develop and mature into immunocompetent cells.
Secondary Lymphoid Organs
Organized tissues like the spleen and lymph nodes where mature lymphocytes encounter antigens and initiate immune responses.
Skin-associated lymphoid tissue (SALT)
Diffuse lymphoid tissue containing Langerhans cells and intraepidermal lymphocytes that provides immune surveillance in the skin.
Pathogen-associated molecular patterns (PAMPs)
Conserved microbial structures (e.g., Lipopolysaccharide, Peptidoglycan) recognized by PRRs that are absent from host cells.
Toll-Like Receptors (TLRs)
A major class of pattern recognition receptors that function as signalling receptors on cell surfaces or intracellular membranes to trigger cytokine production and inflammation.
Cytotoxic T lymphocytes (CTLs)
Differentiated CD8+ T cells that kill infected or abnormal host cells using lytic enzymes and proteins.
Plasma cells
Differentiated B cells that secrete antibodies to neutralize toxins or viruses and enhance opsonisation.
Superantigens
Proteins that bypass normal antigen specificity by directly linking MHC class II and T-cell receptors, causing massive cytokine release or a "cytokine storm."
Fab Region
The portion of an antibody containing variable regions that specifically binds to target antigens.
Fc Region
The stem of the antibody structure that binds to immune cells and activates complement proteins.
IgG
The most abundant serum immunoglobulin (∼80%) which crosses the placenta and is the primary goal of vaccination.
IgM
The pentameric antibody produced first during a primary immune response, excellent for agglutination and complement activation.
IgA
Immunoglobulin found in mucosal secretions (tears, saliva, breast milk) that prevents microbial adherence to mucosal surfaces.
Neutralisation
The process where antibodies bind toxins or viruses to block their interaction with host cells.
Agglutination
The cross-linking of cells or particles by antibodies to promote easier phagocytosis.
Diapedesis
The process, also known as extravasation, where leukocytes squeeze between endothelial cells to leave capillaries and enter tissues.
Granuloma
An organised, walled-off collection of immune cells formed when pathogens cannot be eliminated by phagocytes during chronic inflammation.